| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |